Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Clinical trial NCT00383929 · COMPLETED
Trial details
- NCT number
- NCT00383929
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-08-01
- Enrollment
- 1979
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.